Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Island Pharmaceuticals Limited has disclosed full compliance with ASX Corporate Governance Council recommendations for the financial year ended 30 June 2024, as detailed in their Corporate Governance Statement available on their website. The company has adhered to principles such as board and management roles, director appointment checks, and director agreements, ensuring transparency and accountability in its governance practices. The statement, approved by the board and current as of 29 August 2024, reflects the company’s commitment to solid management foundations and oversight.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.